MDGL icon

Madrigal Pharmaceuticals
MDGL

Overview Fund Activity

32 hedge funds and large institutions have $23.6M invested in Madrigal Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+1
Holders Change %
+3.23%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RSCM
Rock Springs Capital Management
Maryland
$3.47M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
$6.16M
3
Millennium Management
Millennium Management
New York
$486K
4
Goldman Sachs
Goldman Sachs
New York
$321K
5
Northern Trust
Northern Trust
Illinois
$306K

Top Sellers

1
PP
Paloma Partners
Connecticut
$0
2
PAM
Panagora Asset Management
Massachusetts
$8K
3
Vanguard Group
Vanguard Group
Pennsylvania
$1.37M
4
LTFS
Ladenburg Thalmann Financial Services
Florida
$1K
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$1K – – –
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$1K +$67 +3 +7%
GEA
28
Glen Eagle Advisors
New Jersey
$216 – – –
PP
29
Paloma Partners
Connecticut
– -$161K -10,781 Closed
1
2